State Of Alaska, Department Of Revenue Ligand Pharmaceuticals Inc Transaction History

State Of Alaska, Department Of Revenue

$8.78 Billion
Q1 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 9,985 shares of LGND stock, worth $996,103. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,985

Previous 10,084 0.98%

Holding current value

$996,103

Previous $720,000 1.25%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$68.64 - $89.2 $6,795 - $8,830	-99 Reduced 0.98%	9,985 $729,000
Q4 2023 Jan 19, 2024	SELL	$49.57 - $72.63 $3,668 - $5,374	-74 Reduced 0.73%	10,084 $720,000
Q3 2023 Oct 16, 2023	SELL	$58.86 - $72.67 $37,611 - $46,436	-639 Reduced 5.92%	10,158 $608,000
Q2 2023 Jul 24, 2023	SELL	$69.53 - $79.33 $13,419 - $15,310	-193 Reduced 1.76%	10,797 $778,000
Q1 2023 Apr 17, 2023	SELL	$65.67 - $77.08 $12,148 - $14,259	-185 Reduced 1.66%	10,990 $808,000

Q4 2022 Jan 11, 2023	BUY	$61.72 - $96.74 $4,320 - $6,771	70 Added 0.63%	11,175 $746,000
Q3 2022 Oct 20, 2022	SELL	$0.01 - $107.56 $16 - $177,258	-1,648 Reduced 12.92%	11,105 $956,000
Q2 2022 Jul 08, 2022	BUY	$74.52 - $117.06 $83,835 - $131,692	1,125 Added 9.67%	12,753 $1.14 Million
Q1 2022 Apr 14, 2022	SELL	$94.99 - $151.56 $19,472 - $31,069	-205 Reduced 1.73%	11,628 $1.31 Million
Q4 2021 Jan 12, 2022	SELL	$127.69 - $165.85 $42,776 - $55,559	-335 Reduced 2.75%	11,833 $1.83 Million
Q3 2021 Oct 07, 2021	BUY	$102.33 - $144.73 $980,526 - $1.39 Million	9,582 Added 370.53%	12,168 $1.7 Million
Q2 2021 Jul 12, 2021	SELL	$113.03 - $155.64 $1,921 - $2,645	-17 Reduced 0.65%	2,586 $339,000
Q1 2021 Apr 09, 2021	SELL	$99.52 - $215.83 $995 - $2,158	-10 Reduced 0.38%	2,603 $396,000
Q4 2020 Jan 08, 2021	SELL	$80.55 - $106.05 $10,149 - $13,362	-126 Reduced 4.6%	2,613 $259,000
Q3 2020 Oct 05, 2020	SELL	$89.56 - $126.72 $10,299 - $14,572	-115 Reduced 4.03%	2,739 $261,000
Q2 2020 Jul 06, 2020	BUY	$68.28 - $123.65 $1,024 - $1,854	15 Added 0.53%	2,854 $319,000
Q1 2020 Apr 06, 2020	SELL	$63.37 - $107.88 $3,041 - $5,178	-48 Reduced 1.66%	2,839 $206,000
Q4 2019 Jan 07, 2020	SELL	$96.94 - $113.59 $47,985 - $56,227	-495 Reduced 14.64%	2,887 $301,000
Q3 2019 Oct 02, 2019	BUY	$86.25 - $120.16 $291,697 - $406,381	3,382 New	3,382 $336,000
Q4 2018 Jan 10, 2019	SELL	$128.36 - $272.13 $901,343 - $1.91 Million	-7,022 Closed	0 $0
Q3 2018 Oct 09, 2018	BUY	$211.18 - $274.49 $11,614 - $15,096	55 Added 0.79%	7,022 $1.93 Million
Q2 2018 Jul 10, 2018	BUY	$150.77 - $207.98 $24,123 - $33,276	160 Added 2.35%	6,967 $1.44 Million
Q1 2018 Apr 19, 2018	BUY	$138.63 - $182.62 $360,438 - $474,812	2,600 Added 61.8%	6,807 $1.12 Million
Q4 2017 Jan 19, 2018	BUY	$128.36 - $147.04 $8,985 - $10,292	70 Added 1.69%	4,207 $576,000
Q3 2017 Oct 16, 2017	BUY	$120.91 - $137.94 $500,204 - $570,657	4,137	4,137 $563,000

Others Institutions Holding LGND

# of Institutions

238

Shares Held

16.5M

Call Options Held

77.9K

Put Options Held

25K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.68B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account

State Of Alaska, Department Of Revenue Ligand Pharmaceuticals Inc Transaction History